FDA Ad Division Will Increase Focus On Outcomes Claims After Reorganization
Executive Summary
FDA's reorganized Division of Drug Marketing, Advertising & Communication will be increasing its focus on promotions based on outcomes data, Division Director Tom Abrams said during the Drug Information Association's annual meeting in Chicago June 18